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“It is an abstract change without object. Am I the one who has changed?” – Jean 
Paul Sartre (Nausea) 
 
 
 
 
  
ABSTRACT 
The longevity and turnover of the different constituent cells of an organism define 
its development, size, health, and biological age. The present thesis discusses the 
renewal rates and functions of cells in several organs and tissues: peripheral 
blood, bone marrow, intestine and central nervous system. 
By applying a recently developed method to assess average cell age to peripheral 
T cell subsets, we provide evidence that in humans the thymus remains active 
beyond the age of 30 and that naïve T cell renewal rates slowly decrease 
throughout life. We further examined how turnover rates can impact the total naïve 
T cell population, by applying a variety of additional mathematical and 
computational models as well as functional assays. Using these approaches we 
propose a model by which clonal diversity can be sustained regardless of the 
spatial location of the constituent cells. Furthermore, we identify a subset of 
individuals above the age of 65 who exhibit a dramatic increase in turnover despite 
having no overt pathological conditions. Given recent evidence that aging is 
associated with immunological dysfunction, this observation highlights a subset of 
the population that may be more susceptible to new infections and less receptive 
to vaccinations. (PAPER I). 
We determined that plasma cells have different renewal rates depending on the 
subpopulation and, more importantly, depending on the niche. Both the bone 
marrow and the intestine harbor plasma cell responders to antigens from childhood 
exposures. However, bone marrow plasma cells (PAPER II) renew much faster 
than their intestinal counterparts (PAPER III). In the small intestine, some plasma 
cells can persist for decades without being replaced or undergoing further divisions 
(PAPER III). The differences described suggest different mechanisms of immune 
memory maintenance possibly due to different pressures in the niches. These 
results also demonstrate that plasma cells in the bone marrow and in the intestine 
are likely to be differentially impacted by treatments that target fast renewing cells 
(PAPER II and III). 
In mammals, the central nervous system (CNS) governs many of the body’s vital 
functions. Disturbance to cell homeostasis such as microglia depletion or spinal 
cord injury have tremendous consequences. Our data reveals that the vast 
majority of the microglia population in the human cortex undergoes constant 
renewal albeit at a slow rate. Microglia are key regulators of the CNS; the 
progressive turnover of this cell population ensures the constant presence of a 
pool of young microglia (PAPER IV). Another example of a self-sustaining cell 
population in the CNS are ependymal cells. We showed that these resident stem 
cells are capable of fast proliferation and differentiation in response to spinal cord 
injury. The progeny of ependymal cells play a crucial rule in scar formation helping 
preventing secondary enlargement of the wound and consequently preventing 
further deterioration. Interestingly, ependymal cells are incapable of responding to 
injury and originate progeny if cell division is blocked, demonstrating how the 
processes of cell-renewal and differentiation can be interconnected (PAPER V). 
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1 AIMS 
The overall aim of the present thesis is to discuss cell proliferation and renewal, to 
explore different examples of this phenomenon, and to make a case for its 
relevance. It is not straightforward to determine when or why a cell divides. The 
rate of turnover can differ significantly between cell types depending on a variety of 
variables such as their origin, function, and location. Nevertheless, the instructions 
for when and why a cell initiates the process is many times scripted in detail in the 
“fine print”. The research in this field aims to investigate the inheritable and 
environmental instructions that govern cell renewal. 
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2 CELL RENEWAL 
2.1 CELL RENEWAL 
Cell renewal is the process by which cells in a given system are replaced. Typically 
in a mammalian tissue, the two sides of this coin are mitotic cell division and cell 
death. In homeostasis, the maintenance of a tissue’s function and morphology is 
achieved by the equilibrium between the two. Cell renewal rates vary substantially 
between tissues and frequently reflect the tissue’s function. For instance, due to 
persistent aggression by the digestion process, the intestinal epithelium is 
constantly renewed. In such a system, cells are replaced by morphologically and 
functionally similar ones on regular intervals (Barker 2014). The deregulation of the 
balance between cell death and mitotic cell division can lead to either tissue 
degeneration or neoplasia. Indeed, tissues with higher cell turnover have a higher 
probability of developing tumors (Tomasetti and Vogelstein 2015). 
Mitotic cell division is the process by which one cell gives origin to two cells with 
identical DNA content. As a result, every pair of daughter cells comes from a 
previously existing one. Cell death is the event that terminates the cell’s 
physiological functions. Two communally described forms of cell death are 
apoptosis and necrosis (Nikoletopoulou, Markaki et al. 2013). The former is 
programmed and well coordinated, with little impact to the surrounding tissue 
(Nikoletopoulou, Markaki et al. 2013). The latter is chaotic, often caused by 
external factors and usually followed by inflammation (Los, Mozoluk et al. 2002). 
Apoptosis is characterized by the activation of caspases, permeabilization of the 
mitochondrial membrane, DNA fragmentation and chromatin condensation (Green 
2005). In a necrotic cell it is common to see swollen organelles and disruption of 
the plasma membrane (Schweichel and Merker 1973, Leist and Jaattela 2001). 
Apoptosis is involved in the selection of T cell precursors in the thymus (Stritesky, 
Jameson et al. 2012). In a process know as “death by neglect”, T cell precursors 
with low affinity T cell receptors (TCRs) do not receive the necessary signals for 
positive selection and thus enter apoptosis (Stritesky, Jameson et al. 2012). In 
addition, if these cells show high affinity for self-antigens, they also undergo 
apoptosis in a process designated “clonal deletion” (Stritesky, Jameson et al. 
2012).  
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2.2 WHEN TO STOP? 
One long lasting question in biology relates to the rules that govern the stop of 
growth during development and the maintenance of cell number in an adult tissue. 
A possible explanation relates to the existence of a limited quantity of growth 
factors and survival factors in a system and the inevitable competition for those 
resources (Raff 1996). The loss of cells leads to a wider availability of these factors 
per cell, hence promoting cell division. The increase of cell number decreases the 
availability of these factors per cell, hence suppressing cell division. Another 
possibility is the existence of a negative feedback loop created within the system. 
In other words, the cells of a given tissue produce molecules that inhibit their own 
cell proliferation. When the system reaches the right cell number it is producing 
enough inhibitors to stop its own grown (Raff 1996, McPherron, Lawler et al. 1997, 
Huang, Ma et al. 2006). 
2.3 RELEVANCE 
Determining the rates of cell renewal in different tissues and systems is crucial for 
a better understating of the homeostatic processes of tissue maintenance, the 
response to insults, and abnormal proliferation. Furthermore, investigating the 
mechanisms responsible for the induction and repression of cell expansion and 
renewal can help in the design of therapies for disorders associated with 
degeneration such as Alzheimer’s disease, for diseases associated with 
uncontrolled proliferation such as neoplasias, and for lesions such as spinal cord 
injuries. 
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3 MEASURING CELL TURNOVER IN HUMANS 
 
The wide availability of labeling strategies for experimental animals and for in vitro 
experiments has made cell proliferation measurements common. However, 
assessing cell turnover in humans is still far from trivial and the techniques 
available are limited. 
3.1 KI-67 
Ki-67 is a protein absent in G0 but expressed throughout the different phases of the 
cell cycle:  G1, S phase, G2 and mitosis (Scholzen and Gerdes 2000). Ki-67 is 
commonly used as a marker of cell division in immunocytochemistry, 
immunohistochemistry, as well as in flow cytometry. However, this method is not a 
direct measurement of turnover and its use requires certain assumptions to be 
made concerning cell cycle length. Furthermore, it is prone to overestimate cell 
proliferation as cells with G1/S blockage will continue to express Ki-67 although 
they are stopped in G1 or are destined to enter apoptosis (Combadere, Blanc et al. 
2000). It is worth mentioning that, naturally other cell cycle markers can be used to 
assess DNA replication (Williams and Stoeber 2007). 
 
3.2 THYMIDINE ANALOGS 
Thymidine analogs are incorporate into the genomic DNA during S phase. Data 
from Ki-67 and thymidine analogs are not directly comparable and the length of the 
cell cycle should be take into account, since the S phase represents approximately 
half of the cell cycle (Cameron and Greulich 1963). To a certain extent, data 
heterogeneity from thymidine analogs experiments can be explained by the 
unpredictable incorporation of these extracellular compounds through the salvage 
pathway (Busch, Neese et al. 2007). Finally, it is important to point out that if 
labeled cells continue to proliferate after the labeling period, the newly generated 
cells will also be labeled, leading to an 
over estimation of cell division (Busch, 
Neese et al. 2007). 
 
3.3 STABLE ISOTOPE LABELING 
Stable isotope labeling experiments 
similarly to any pulse-chase experiment, Time
La
be
l
Fig.1
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require a period of labeling (red) and a period of de-labeling (grey) (Fig. 1). In 
broad terms, the labeling period provides information on cell proliferation and the 
de-labeling period provides information on cell death (Asquith, Debacq et al. 2002). 
An estimation of cell turnover can be achieved from this type of DNA-labeling 
assays, once a mathematical model that recapitulates the data is constructed 
(Asquith, Debacq et al. 2002). Typically, many models with different proliferation 
and death rates would be tested on the data in order to find the one that best fits 
(Asquith, Debacq et al. 2002). As a simple example, one begins with an educated 
guess of the model (Fig. 2A) and then increases or decreases the proliferation and 
death rates until the model fits the data (Fig. 2B) (Asquith, Debacq et al. 2002). 
Deuterated water is a reliable DNA-
labeling strategy and it labels newly 
synthetized nucleotides with the 
hydrogen isotope deuterium (2H). In the 
organism, 2H is incorporated into 
nucleotides through de novo synthesis 
making its incorporation into DNA more 
consistent and predictable then the 
previously mentioned thymidine analogs 
(Busch, Neese et al. 2007). In addition, 
deuterium has not been reported as 
significantly toxic despite decades of 
studies in humans and experimental 
animal models (Busch, Neese et al. 
2007).  
Nonetheless, heavy water studies have a limited window of time to detect cell 
exchange, just like any other short term labeling assay. Varying the length of the 
labeling period can dramatically change 
the number of labeled cells (Fig. 3). In 
populations with slow exchange rates, if 
the labeling period is too short (period 
1), nearly no cells will be detected, 
thereby making the interpretation of the 
results difficult (Fig. 3). This is 
particularly problematic in 
Fig.3
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heterogeneous populations where the 
fast dividing subpopulations will mask 
the contribution of the slower ones 
(Asquith, Debacq et al. 2002). In 
addition, if newly produced cells 
(detected within the labeling period) do 
not leave the pool during the chase 
period it becomes challenging to 
determine the dynamics of the population (Fig. 4). In these situations one should 
extend the chase period when possible. 
 
3.4 CARBON-14 
Carbon-14 (14C) is a rare but naturally occurring isotope of carbon. The 
atmospheric level of 14C has been low 
and constant for thousands of years 
(Levin, Naegler et al. 2010). During the 
cold war, due to nuclear bomb testing 
the level of environmental 14C 
dramatically increased (Levin, Naegler 
et al. 2010). The Partial Test Ban Treaty 
was signed in 1963, and ever since 
most nuclear tests have not been performed above ground. As a result, the 14C 
level peaked in the atmosphere in 1964 and has been progressively decreasing 
(Fig.5) (Levin, Naegler et al. 2010). This decline is not due to radioactive decay 
(half-life 5730 years) but mainly due to diffusion in the oceans and incorporation 
into the biotope (Levin and Kromer 2004). Through photosynthesis, 14CO2 enters 
the food chain, hence the 14C content in biomolecules reflects the atmospheric 14C 
level at the moment of synthesis. Carbon in genomic DNA is almost exclusively 
exchanged by cell division and the contribution of DNA methylation and repair is 
negligible (Spalding, Bhardwaj et al. 2005, Bergmann, Liebl et al. 2012, Ernst, 
Alkass et al. 2014) even in the case of stroke when DNA repair is increased 
(Huttner, Bergmann et al. 2014). By measuring the 14C content in the DNA of a cell 
population (Fig. 5, y-axis) and determining its intersection with the atmospheric 14C 
level, it is possible to assess the average time of birth (Fig.5, x-axis) of that 
population (Spalding, Bhardwaj et al. 2005). In contrast to short-term labeling 
Fig.4
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experiments, 14C assessment of turnover reflects the cumulative history of cell 
division of the population of interest (Spalding, Bhardwaj et al. 2005). Carbon 
dating has proven to be a valuable tool for detecting the presence of sub-
populations of non-dividing cells within a potentially heterogeneous population 
(PAPER I) since these cells conserve the 14C level from the date of birth of the 
individual. Cell populations can also contain sub-populations of fast dividing cells. 
However, assessing the presence of these cells is more challenging since their 14C 
profile is not unique, and can be the result of many different possible combinations 
of 14C “dilution” throughout the years. Furthermore, due to the slow pace of change 
of the environmental levels of 14C, it is hard to precisely measure the turnover rate 
of cell populations that renew fast. 
Presently, to obtain the most complete picture of cell dynamics in human cell 
populations one should probably use a combination of carbon dating and heavy 
water labeling. This would provide data on the population as a whole, on the 
presence of non-dividing sub-populations, as well as detailed information on 
subpopulations of fast proliferating cells.   
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4 REGULATION AND FUNCTION OF CELL PROLIFERATION 
4.1 MAINTENANCE OF CLONAL DIVERSITY 
A group of cells that share a common ancestor in their recent division history can 
be broadly referred to as a clone. Clonality and the maintenance of diversity is 
likely to play an important role in various tissues. However, it is notably hard to 
retrospectively reconstruct phylogenetic trees in humans (Salipante and Horwitz 
2006). Both T cell and B cell clones, though, share unique genetically encoded 
antigen receptors, making these cells ideal candidates for studying how clonality is 
affected by population level changes in cellular turnover. Akin to the species level, 
diversity at the cellular level might be evolutionary advantageous, since there are 
individuals different enough within a population to withstand a variety of 
environmental changes. In the case of T cells and B cells this is particularly true, 
as their unique antigen receptors impart specificity for foreign organisms and 
proteins and thus clonal diversity is inextricably linked to the immunological 
potential of the populations as a whole. 
4.1.1 The thymus 
The ancient Greeks referred to the thymus as “the seat of the soul” (Nishino, 
Ashiku et al. 2006). Probably, the first observation of thymic involution was made 
by Galen of Pergamum (130-200 AD) who referred to it as an “organ of mystery” 
when describing its shrinkage throughout life (Peltier 2003). The thymus is a 
primary lymphoid organ responsible for the maturation of bone marrow-derived T 
cell precursors into circulating naïve T cells (Miller 2011). For many years the 
thymus was considered a vestigial organ, since it did not react to infections in the 
same fashion as other lymphoid organs and since thymectomized adult mice were 
not immunodeficient (Miller 2011). This sentiment was summed up well by the 
Nobel Laureate Sir Peter Medawar who in 1963 wrote: “We shall come to regard 
the presence of lymphocytes in the thymus as an evolutionary accident of no very 
great significance” (Medawar 1963). Nonetheless, later studies on mice 
thymectomized at birth, revealed that these animals did in fact have lower 
lymphocyte counts and were more prone to certain viral infections and tumors 
(Miller 1961, Miller 1962, Burnet 1971). 
4.1.2 Thymus size: a cautionary tale 
The first written references to what is in known as ‘sudden infant death syndrome’ 
date back to 480-406 BC (Russell-Jones 1985). In the late 1800s, several victims 
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of sudden infant death were autopsied and diagnosed with Status 
thymicolymphaticus, a condition characterized by an enlarged thymus that 
pressures the trachea and suffocates the child (Russell-Jones 1985). Between 
1926 and 1957 thousands of infants were subjected to ionizing radiation as a 
treatment for this condition (Adams, Shore et al. 2010). Before the 1930s most 
bodies in anatomy classes came from the poor and it was unknown at the time that 
a life of poverty, chronic stress, malnutrition, and infection can all cause thymic 
involution, thus anatomists were incorrect in their measurements of the size of a 
healthy human thymus (Sapolsky 1997). In 1993 it was shown that individuals that 
went through the previously mentioned ionizing treatment were 24.3 times more 
likely to develop thyroid cancer than the average New Yorker of the same age and 
sex (Shore, Hildreth et al. 1993). 
4.1.3 Of mice and men 
Microorganisms keep the immune system under an enormous evolutionary 
pressure due to their short life spans 
and high mutation rates (McDade and 
Worthman 1999). After 65 million years 
of divergent evolution, humans and 
mice are quite distinct: mice have much 
shorter lifespans than humans, have 
much smaller body sizes and occupy 
different ecological niches (Mestas and Hughes 2004). There is a large number of 
variables that might explain differences in cell turnover rate across species, 
therefore it is important to assess it in humans whenever possible. This is 
particularly important for immune cells, since the majority of the laboratory animals, 
live in pathogen free barrier facilities (Beura, Hamilton et al. 2016). 
Maintaining a diverse T cell repertoire for many years is not a trivial task (PAPER 
I), in mice it has been shown that the naïve T cell population is maintained 
throughout life primarily by thymic production (den Braber, Mugwagwa et al. 2012), 
thus new and diverse T cells are constantly joining the pool. In adult humans 
however, our data supports the view that the major source of new cells is the 
peripheral division of existing naïve T cells (PAPER I). This raises the question of 
how the repertoire is being maintained. 
Fig.6
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4.1.4 T cell repertoire 
A diverse naïve T cell repertoire is crucial for proper primary immune responses 
since different T cells recognize different antigens from a single pathogen (Fig. 6). 
The proliferative capacity of lymphocytes has been known for decades, in the wise 
words of Lord Florey (1954): “Nothing of importance is known regarding the 
potentialities of lymphocytes other than that they move and that they reproduce 
themselves” (Florey 1954). New naïve T cells are added to the peripheral pool 
either by thymic production or by division of existing ones (Fig. 7). Thymic 
production increases diversity, since each new cell expresses a unique T cell 
receptor (Fig. 7). Peripheral division decreases the relative diversity of the pool by 
diluting the frequency of smaller clones with each division of a larger one (Fig. 7). 
Previous studies have reported naïve T cell turnover estimates, varying from 
months to years (Michie, McLean et al. 1992, Neese, Misell et al. 2002, Macallan, 
Wallace et al. 2004, Vrisekoop, den 
Braber et al. 2008). Understanding the 
turnover dynamics of these cells 
throughout life allows the prediction of 
how diverse the repertoire is (PAPER I). 
In other words, by determining the 
relative production of each source of 
new cells and by evaluating production 
changes throughout life, it is possible to 
estimate the average size and the 
maximum size of clones in individuals of different ages (PAPER I). In order to 
dissect thymic production from peripheral production, two main data sets are 
necessary: (1) T-cell receptor excision circles (TREC) measurements (Douek, 
Betts et al. 2001) and (2) data on cell age (PAPER I). (1) In order to form unique 
TCRs, T cells in thymus must undergo TCR rearrangement, a process where the 
portions of genomic DNA that code for the receptor (V, D and J gene segments) 
are recombined generating a functional receptor (Hazenberg, Verschuren et al. 
2001). The excised regions of genomic DNA generated during this process, 
termed TRECs, form circular bits of DNA that persist in cells for extended periods 
of time and that get diluted out in the pool as the cells divide (Hazenberg, 
Borghans et al. 2003). This makes TRECs good makers of cell division history at 
the population level (Hazenberg, Verschuren et al. 2001). (2) As previously 
Fig.7Thymus
Periphery
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mentioned, 14C dating allows for the 
determination of cell age and offers a 
comprehensive view of the turnover 
history of a cell population, making it an 
ideal tool for these types of studies. 
Simply based on TREC content and cell 
number it is not possible to properly 
estimate thymic production (Fig.8, grey 
area); indeed, information on cell age is 
needed to obtain a more reliable measurement  (Fig.8, red dashed line). In more 
detail, Fig. 8 shows in grey, predictions of thymic output based on cell age 
assumptions varying from 1 to 13 years and in red predictions of thymic output 
using known cell age (our model). 
We predicted that the average clone size is maintained remarkably stable 
throughout life (PAPER I), which helps explain the capacity of humans to efficiently 
mount primary immune responses throughout adulthood despite a large decrease 
in thymic production. This observation suggests the existence of mechanisms that 
favor the proliferation of less expanded clones. Otherwise, should any cell have an 
equal chance of dividing, regardless its clonal origin a paradigm similar to 
"patrimonial capitalism" (Piketty and Goldhammer 2014) would arise. This 
economic concept describes inheritance as a large contributor for the maintenance 
and expansion of family wealth (Piketty and Goldhammer 2014). Similarly, we 
believe that in the absence of a regulatory mechanism, early settlers would have 
more time to expand their clones, and if all cells were equally competent to 
respond to homeostatic division cues, large clones would outcompete small clones 
for resources and become very large later in life (PAPER I). The mechanism 
proposed in PAPER I suggests that the probability of a naïve T cell to divide 
decreases with the expansion of its clone, offering one potential mechanism to 
prevent this from occurring. 
4.1.5 Restrictions to Clonal Expansion 
CD31 (PE-CAM1) is considered a marker of recent thymic emigrants. Evidence for 
this comes from several observations: (1) CD4+ T cells in the thymus are almost 
uniformly CD31+, (2) levels of CD31 expression decrease within the naïve CD4+ T 
cell compartment throughout life, (3) and CD31- cells have lower TREC content 
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than their CD31+ counterparts (Kimmig, Przybylski et al. 2002, Kohler and Thiel 
2009). 
CD31- naïve CD4+ cells are less capable of expanding in response to IL-7 than 
CD31+ cells (PAPER I) (Azevedo, Soares et al. 2009). Importantly, this 
homeostatic expansion is happening without activation and consequently without 
differentiation into effector and memory cells (PAPER I). Nonetheless, in the 
presence of tumor necrosis factor alpha (TNFα) both CD31+ and CD31- promptly 
proliferate, indicating that CD31- are not exhausted but simply quiescent cells 
(PAPER I). Additionally, both cell types are capable of differentiating into effector 
and memory phenotypes in response to activation signals (anti-CD3/anti-CD28), 
reinforcing the idea that both cell types are competent. Also, we show that the 
response to proliferative signals (IL-7, 
anti-CD3/IL-7 or TNFα/IL-7) in both the 
CD31- and CD31+ compartment is 
dependent on the NF-κB pathway. 
Interestingly we also observed that 
basal NF-κB phosphorylation levels 
were positively correlated with the 
expression of CD31 in CD4+ naïve T 
cells providing a mechanism for the 
increased proliferative capacity of 
CD4+CD31+ cells in response to 
homeostatic cues (Figure 9) (PAPER I). 
Finally, the expression of CD31 is not 
binary but more of a continuum where CD4+ naïve T cells have a spectrum of 
expression levels (PAPER I). In summary, these results are consistent with a 
mechanism where naïve T cell expansion in the periphery leads to a progressive 
loss of CD31 expression coincident with a reduction in basal NF-κB activation. 
Together, these changes lead to a reduced capacity to proliferate in response to 
homeostatic survival signals such as IL-7. 
It can be inferred that the size of individual clones may be limited by an intrinsic 
regulatory mechanism that favors the division of non-expanded clones over highly 
expanded clones, which would be expected to have reduced CD31 expression 
(Figure 9) (PAPER I). While it remains unknown the precise factors that lead to the 
reduction in CD31 expression, this model is consistent with data on naïve T cell 
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turnover rates (PAPER I), TREC content (Douek, Betts et al. 2001), as well as 
current estimates of total naïve T cell repertoire diversity (Qi, Liu et al. 2014). 
To a certain extent, the coordinated behavior of naïve T cell clones resembles that 
of an ant colony. In the context of emergence of complexity, Jad Abumrad, (funder 
and host of Radiolab) wondered: “Where does organization come from? […] How 
do you get the complexity of an ant colony if there is no leader and everyone in 
town is stupid?”. Similarly to ants, cells are capable of completing complex tasks 
without top down orders, but instead using a vast number of individuals that follow 
a simple set of rules. It is easy to imagine that there is an incentive at the cellular 
level to utilize as many resources as possible and to keep dividing. However, from 
an evolutionary point of view, the fittest organism is probably one with mechanisms 
for containing uncontrollable cell proliferation. In the case of naïve T cells, 
permanently turning off cell division is not an option. Hence, a self-regulatory 
mechanism that progressively tunes proliferation down at the clonal level 
regardless of anatomic or temporal factors is a simple and yet highly effective 
solution (PAPER I). 
 
4.2 CELL LONGEVITY: ILLUSION OF CERTAINTY 
Circulating naïve B cells are the progeny of B cell precursors in the bone marrow 
(Radbruch, Muehlinghaus et al. 2006, Nutt, Hodgkin et al. 2015). Naïve B cells can 
mature into a variety of B cell subsets found in the spleen, lymph nodes, or in the 
peritoneal and pleural cavities (Radbruch, Muehlinghaus et al. 2006, Nutt, Hodgkin 
et al. 2015). Once activated by their cognate antigen, B cells proliferate quickly and 
can differentiate into plasmoblasts and short-lived plasma cells, both capable of 
producing antibodies (Radbruch, Muehlinghaus et al. 2006, Nutt, Hodgkin et al. 
2015). Some B cells enter germinal center reactions and become memory B cells 
or long-lived plasma cells. In the germinal center, B cells proliferate and undergo 
somatic hypermutation in the antibody encoding genes (Radbruch, Muehlinghaus 
et al. 2006, Nutt, Hodgkin et al. 2015). Additionally, they are selected based on 
antibody affinity and can undergo class switch to alter the functionality of the 
antibody produced by each cell (Radbruch, Muehlinghaus et al. 2006, Nutt, 
Hodgkin et al. 2015). The result is B cells with refined antigen recognition. Memory 
B cells can also give rise to long-lived plasma cells and the latter can be found in 
different niches such as the bone marrow, secondary lymphoid organs, and 
inflamed tissue (Radbruch, Muehlinghaus et al. 2006, Nutt, Hodgkin et al. 2015). 
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Some studies have suggested that plasma cells are long-lived, based on the fact 
that 60% of the bone marrow plasma cells in mice can live longer than 90 days 
(Manz, Thiel et al. 1997) and that antigen specific antibody titers have been shown 
to be maintained for over 25 years in humans (Amanna, Carlson et al. 2007). On 
the other hand, in inflamed tissue when the inflammation is cleared, the survival 
niches disappear and the plasma cells die as a consequence (Radbruch, 
Muehlinghaus et al. 2006). 
This is a relevant but still controversial subject.  Experimental animals are not ideal 
to assess the longevity of a population that responds to pathogens. In the wild, 
new bugs are constantly stimulating the immune system and newly produced 
plasma cells are likely to compete for survival niches with existing ones. In a 
pathogen free barrier facility, following the initial response induced by the 
experimental vaccination or infection, and in the absence of secondary infections, 
it is possible that no turnover will occur as a result of a lack of competition driven 
by new B cell activation events. Long lasting immune memory (mediated by B cells 
or T cells) is unquestionable, but if it is maintained by long-lived cells or by 
continuously renewing cells, remains generally unknown. The bone marrow has 
historically been considered the main residence for long-lived plasma cells 
(Radbruch, Muehlinghaus et al. 2006, Nutt, Hodgkin et al. 2015), but our results 
contradict this hypothesis (PAPER II). Although, isolated plasma cells produced 
antibodies against antigens from childhood vaccines, our data is inconsistent with 
the presence of a large population of long-lived cells (PAPER II). Additionally, 
preliminary results on peripheral memory B cells suggest that these cells might be 
in average older than bone marrow plasma cells, offering an alternative 
explanation for immune memory preservation where plasma cells in the bone 
marrow are constantly replaced by slow-dividing memory B cells following an 
amplification step (PAPER II).  
As mentioned above, plasma cells can be found in different survival niches, and 
we showed that the human small intestine houses large numbers of truly long-lived 
plasma cells (PAPER III). Here, plasma cells were defined as CD27+/CD38+ and 
further sub-divided into three populations: CD45+/CD19+ (double positives), 
CD45+/CD19- (single positives) and CD45-/CD19- (double negatives) (PAPER III). 
In pancreatic transplants, part of the donor’s small intestine was transplanted into 
the recipient. One year after the transplant, biopsies of small intestine were 
collected and the percentage of replacement of donor cells by recipient cells was: 
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32% in the double positive, 2.3% in the single positives and only 0.01% in the 
double negatives (PAPER III). By measuring the average age of each population 
using 14C analysis, we determined that double positive cells are continually 
renewed, single positives are on average 8 years old and double negatives are on 
average 18 years old (truly long-lived plasma cells) (PAPER III). In addition, we 
sequenced the heavy-chain variable region of the three cell populations. The 
results of this experiment revealed that in terms of shared clones, the single 
positive plasma cells are situated in between the double positive and the double 
negative ones (PAPER III). The intermediate phenotype, replacement rate, cell 
age, and clone overlap of the single positive population suggests that it might be a 
developmental stage between the other two (PAPER III).  
These results provide strong evidence for an important contribution by long-lived 
plasma cells to the maintenance of humoral immunity at least in the 
gastrointestinal niche (PAPER III). The higher renewal rate in bone marrow plasma 
cells (PAPER II) could be the result of higher competition for survival factors in this 
niche in comparison with the intestine and is the topic of ongoing investigation. 
 
4.3 PROLIFERATION IN THE CNS 
A general theme of the work presented in this thesis is that cells in different 
systems proliferate at much different rates. As an example, cells of the innate 
immune system such as monocytes and neutrophils renew very often (Busch, 
Neese et al. 2007) while many cells of central nervous system (CNS) are 
exchanged slowly (Spalding, Bergmann et al. 2013, Ernst, Alkass et al. 2014, 
Yeung, Zdunek et al. 2014) or not at all (Bhardwaj, Curtis et al. 2006). Microglia 
are the resident macrophages of the CNS and serve a variety of functions, such as 
immune surveillance, affect neurogenesis, synaptic pruning and apoptotic 
clearance (Casano and Peri 2015). Having a healthy microglia population is likely 
to be important for CNS homeostasis, since low numbers of microglia cells can 
result in abnormal behavior and learning disabilities (Parkhurst, Yang et al. 2013). 
We have provided evidence that human microglia renew much faster than other 
cell types in the CNS (Spalding, Bhardwaj et al. 2005, Spalding, Bergmann et al. 
2013, Yeung, Zdunek et al. 2014) at a median rate of 28% a year (PAPER IV). 
With an average age of 4.2 years, not all microglia cells divide simultaneously, 
hence some are newly generated and a few may be over 20 years old (PAPER 
IV). Nonetheless, we found no evidence for the existence of a large population of 
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non-dividing microglia, meaning that the majority of microglia (>96%) in the human 
cortex will eventually be exchanged throughout life (PAPER IV), similarly to what 
has been observed in mice (Askew, Li et al. 2017). 
Lining the ventricles in the brain and the central canal in the spinal cord are a 
group of ciliated cells designated ependymal cells (Del Bigio 2010). In 
homeostasis, these cells are capable of slow self-renewal in the spinal cord 
(PAPER V) (Horner, Power et al. 2000, Meletis, Barnabe-Heider et al. 2008). Much 
like turnover, regeneration involves the substitution of a given number of cells in a 
tissue by new ones. Regeneration however, implies the occurrence of an injury 
and this often leads to scar formation. Spinal cord scarring has both beneficial and 
detrimental effects. On one hand it physically restricts the injury to avoid its spread 
and limits inflammation by sealing the area (Pekny, Johansson et al. 1999, Okada, 
Nakamura et al. 2006, Herrmann, Imura et al. 2008). On the other hand it restricts 
the regeneration of the severed axons (Silver and Miller 2004, Fawcett 2006, 
Okada, Nakamura et al. 2006, Sofroniew 2009). Following spinal cord injury, 
ependymal cells proliferate extensively and give rise to progeny that leave the 
central canal (PAPER V). This progeny is mainly constituted of astrocytes, which 
play a crucial role in scar formation (PAPER V). The scar restricts secondary 
enlargement of the lesion, which could otherwise cause further impairment 
(PAPER V). Interestingly, if proliferation is blocked in ependymal cells these 
became unable to differentiate, as both processes seem to be linked (PAPER V). 
Importantly, we also show that in the regions adjacent to the injury ependymal cell 
progeny exert neurotrophic effects on local neurons, promoting their survival. 
Consequently, if ependymal cell proliferation and migration is blocked there is an 
increased neuronal loss (PAPER V). 
The spinal cord contains illustrative examples of the proliferative capacities of 
different cell types and of how differently cells are programmed to respond to 
environmental challenges. Like ependymal cells (PAPER V), astrocytes and 
oligodendrocytes are slowly maintained by cells of their own lineage, in 
homeostasis (Barnabe-Heider, Goritz et al. 2010). However in response to injury, 
ependymal cells are capable of giving rise to different lineages (PAPER V) 
(Barnabe-Heider, Goritz et al. 2010). Another cell type that contributes to the 
formation of the scar is type A pericytes (Goritz, Dias et al. 2011). Upon spinal cord 
injury, these cells proliferate, migrate to the lesion site, and their progeny forms the 
stromal component of the scar (Goritz, Dias et al. 2011). In summary, the scar 
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formed after spinal cord injury is constituted by an external layer of astrocytes 
originated from duplication of pre-existing astrocytes, followed by a layer of 
ependymal cell-derived astrocytes, and finally by a central stromal region of type A 
pericyte progeny (Sabelstrom, Stenudd et al. 2014). 
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5 FUTURE PERSPECTIVES 
 
Further research into clonal diversity in different stem cell systems will be of great 
help for a better understanding of how cells regulate proliferation and differentiation 
and how these functions are affected by disease. The knowledge that a significant 
number of new naïve T cells are being produced by the thymus throughout the first 
three decades of life and that diversity slowly decreases in adulthood can lead to a 
variety of treatments. For instance: cell cryopreservation early in adulthood for 
autologous transplant later in life; ex vivo expansion of naïve or memory 
populations following fresh collection or cryopreservation; and in vivo expansion by 
manipulation of the NF-κB pathway. This might be particularly relevant for elderly 
individuals with increased naïve T cell proliferation that might be associated to 
lower diversity and consequently to lower responsiveness to new pathogens. 
An important aspect of our studies into the population dynamics of plasma cells is 
the difference between the bone marrow and the intestinal niches. Contrary to 
intestinal plasma cells, bone marrow plasma cells are more likely to be affected by 
drugs targeting fast renewing cells due their short lifespans. This knowledge, can 
contribute to the design of re-vaccination protocols for patients undergoing 
chemotherapy. In addition, this data may lead to a better understanding of the 
different efficacies of injectable versus oral vaccinations. Investigating the 
repertoire overlap between niches will determine if plasma cell clones have a 
preference for a given niche depending on their receptor. If so, this will help 
developing vaccination protocols that target specific niches. 
Determining the homeostatic turnover rate of microglia provides a standard that 
can help us to understand the diseased brain, where this rate is potentially altered. 
Furthermore, it provides clues about how other tissue resident macrophages are 
likely to behave. Also in the CNS, we investigated the function of ependymal cells 
following spinal cord injury.  We found that this population of neural stem cells 
gives origin to a group of astrocytes, crucial for scar formation. Our results suggest 
that further investigation into therapies that promote acute scar formation is 
needed, since it can prevent secondary enlargement of the lesion. 
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